Tag: FDA

CHC_general1

05/04/2018

White House Drug Pricing Initiative Could Include Moves on Generics/Biosimilars, Demonstration Projects and an End to Part D Rebates, Rawson Says

CHC_general2

03/26/2018

FDA Announces Mobile App to Help Consumers Get Drug Info

CHC_offLabel

12/22/2017

FDA To Study Consumer, HCP Ability to Spot Deceptive Drug Ads

CHC_FDA-Regulatory Images1

12/15/2017

FDA Finalizes Guidance on Name Placement, Size and Prominence

CHC_FDA-Regulatory Images1

11/30/2017

OPDP’s Third Enforcement Letter of 2017 Cites Presentation of Risks, Efficacy Claims

CHC_DTCadvertisement1

08/22/2017

FDA Opens Docket on Limiting Risk Communication in DTC Ads

CHC_Legislative1

08/07/2017

Congress Passes FDA User Fee Legislation

CHC_general1

07/31/2017

Inside the Opioid Crisis: The Intersection of Policy, Industry, and Health Outcomes

CHC_washingtonfocus2

06/27/2017

Executive Order Seeks Better Odds for Competitive Drug Pricing